New 2,4-diamino-3,6-dihydro-1,3,5-triazine derivatives, useful for treating disorders associated with insulin resistance syndrome, e.g. diabetes, dislipidemia, obesity or arterial hypertension

摘要

The invention concerns compounds of general formula (I) wherein: R1, R2, R3, R4, R5 and R6 are as defined in Claim 1 . The compounds are useful in the treatment of pathologies related to the insulin-resistance syndrome.